Skip to content
PubMed This is a summary of 19 peer-reviewed journal articles Updated
Ophthalmology

Does Corneal Dystrophy Come Back After a Transplant?

At a Glance

Yes, corneal dystrophy can recur after a corneal transplant. While the surgery replaces the cloudy tissue, the underlying genetic condition remains. Over time, your body's native cells can migrate into the new donor cornea and deposit the same abnormal proteins that originally impaired your vision.

Yes, corneal dystrophy can recur even after a successful corneal transplant [1]. While a transplant replaces your cloudy cornea with clear, healthy donor tissue, the underlying genetic condition still exists in your body. Over time, your own cells can migrate into the new donor cornea and begin depositing the same abnormal proteins that caused your vision problems initially [2][3].

(Note: This guide focuses primarily on stromal corneal dystrophies, such as Lattice, Granular, and Macular dystrophies. If you have an endothelial dystrophy, like Fuchs’ dystrophy, the risk and mechanisms of recurrence are significantly different and generally much lower.)

Why Does It Come Back?

A corneal transplant treats the symptom (the cloudy cornea) but does not cure the root genetic cause of the disease. In conditions like Lattice corneal dystrophy or Granular corneal dystrophy, your DNA contains instructions that tell your corneal cells to produce abnormal proteins [4].

When you receive a transplant, your body’s natural healing process begins. During this process, your native corneal cells (called keratocytes) can slowly migrate from the edges of your original tissue into the new donor graft [5][3]. Once these native cells establish themselves in the clear donor tissue, they continue executing their genetic instructions, gradually depositing abnormal proteins (like amyloid or hyaline) into the new cornea [2][4]. These deposits often start appearing just under the surface (subepithelial) or at the boundary where the donor tissue meets your own tissue (the graft-host interface) [6][7].

Typical Timeframes for Recurrence

The timeline for disease recurrence varies greatly from person to person. However, different types of corneal dystrophies have different behavioral patterns:

  • Lattice Corneal Dystrophy: This type tends to recur faster than other forms [8]. It is not uncommon for early signs of Lattice dystrophy to appear in the graft within a few years after surgery.
  • Granular and Macular Dystrophies: These typically take longer to recur, sometimes remaining clear for a decade or more before visually significant deposits return [9][7].
  • Surgical technique: The type of transplant you receive can also influence recurrence. For example, partial-thickness transplants, known as Deep Anterior Lamellar Keratoplasty (DALK), may leave behind more native cells than full-thickness transplants, called Penetrating Keratoplasty (PK). This residual tissue can sometimes provide a quicker pathway for recurrence deep at the interface of the tissues [10][11].

Warning Signs to Watch For

While your doctor will monitor for microscopic changes, you should also pay attention to how your eye feels and sees between appointments. Signs that the dystrophy may be returning include:

  • A gradual return of blurry or cloudy vision, similar to what you experienced before your transplant.
  • Increased glare or halos around lights, especially at night.
  • A sudden return of sharp eye pain or a feeling that something is stuck in your eye, which could indicate recurrent corneal erosions.

Monitoring with AS-OCT

Because recurrence can happen slowly, regular eye exams are critical. Today, doctors use an advanced imaging tool called Anterior Segment Optical Coherence Tomography (AS-OCT) to monitor your transplant [12].

AS-OCT is a quick, painless, and non-invasive scan that uses light waves to take highly detailed, cross-sectional pictures of your cornea [13]. It allows your eye doctor to:

  • Catch recurrence early: AS-OCT can detect microscopic protein deposits deep within the corneal layers long before they affect your vision or are visible during a standard slit-lamp exam [14][15].
  • Monitor graft health: It helps doctors differentiate between dystrophy recurrence and other transplant complications, such as early graft rejection [16].

What Happens if It Returns?

Finding out that your disease is returning can be disheartening, but an early recurrence does not mean your transplant has failed. If abnormal proteins begin to build up again, your treatment options will depend on where the deposits are located:

  • Superficial (Surface) Recurrences: Doctors can often use a minimally invasive laser treatment called Phototherapeutic Keratectomy (PTK) to gently vaporize surface deposits and restore clear vision [17][18]. This can significantly delay the need for another transplant, and in many cases, PTK can be safely repeated if deposits return again [19].
  • Deep Recurrences: If the abnormal proteins return deep within the cornea (such as at the graft-host interface after a DALK procedure), PTK cannot reach them. In these cases, a repeat corneal transplant (re-grafting) may eventually be necessary [7]. Repeat transplants are a standard and highly successful option for restoring vision when a graft eventually fails or becomes cloudy again.

Common questions in this guide

Why does corneal dystrophy come back after a transplant?
A corneal transplant replaces the cloudy tissue but does not cure the underlying genetic cause of the disease. Over time, your body's native corneal cells can migrate into the new donor tissue and begin depositing the same abnormal proteins that caused your initial vision problems.
How long does it take for corneal dystrophy to return?
The timeline varies depending on the specific type of dystrophy. Lattice corneal dystrophy can show early signs of returning within a few years, while Granular and Macular dystrophies may remain clear for a decade or more before significant deposits form.
What are the signs that my corneal dystrophy is returning?
Symptoms of a recurrence include a gradual return of blurry or cloudy vision, increased glare or halos around lights, or a sudden sharp eye pain. If you experience these changes or a scratching sensation in your eye, you should contact your eye doctor.
Can recurrent corneal dystrophy be treated without another transplant?
If the abnormal protein deposits are near the surface of the cornea, doctors can often use a minimally invasive laser treatment called Phototherapeutic Keratectomy (PTK) to remove them. If the deposits form deep within the cornea, a repeat transplant may eventually be needed.
How will my eye doctor monitor my transplant for signs of recurrence?
Your doctor will likely use a non-invasive imaging scan called Anterior Segment Optical Coherence Tomography (AS-OCT). This tool takes highly detailed, cross-sectional pictures of your cornea to detect microscopic protein deposits long before they affect your vision.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What specific type of transplant did I have (e.g., partial-thickness DALK vs. full-thickness PK), and how does that impact where in the graft a recurrence might start?
  2. 2.How often should we perform AS-OCT scans to proactively monitor my donor graft for microscopic signs of recurrence?
  3. 3.Based on my specific type of stromal dystrophy, what is a realistic timeline for when we might expect to see early protein deposits?
  4. 4.If the dystrophy does return, what criteria will you use to determine if I am a candidate for a laser treatment like PTK versus needing a repeat transplant?
  5. 5.Can you show me the graft-host interface on my AS-OCT scan so I can better understand where the deposits might form?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (19)
  1. 1

    In Vivo Confocal Microscopy Findings in Corneal Stromal Dystrophies.

    Okudan S, Tınkır Kayıtmazbatır E, Bozkurt Oflaz A, Bozkurt B

    Diagnostics (Basel, Switzerland) 2025; (15(2)) doi:10.3390/diagnostics15020182.

    PMID: 39857066
  2. 2

    Biochemical mechanisms of aggregation in TGFBI-linked corneal dystrophies.

    Nielsen NS, Poulsen ET, Lukassen MV, et al.

    Progress in retinal and eye research 2020; (77()):100843 doi:10.1016/j.preteyeres.2020.100843.

    PMID: 32004730
  3. 3

    Histologic Analysis of Porcine Dermal Graft Augmentation in Treatment of Rotator Cuff Tears.

    Christian RA, Stabile KJ, Gupta AK, et al.

    The American journal of sports medicine 2021; (49(13)):3680-3686 doi:10.1177/03635465211049434.

    PMID: 34652242
  4. 4

    Corneal histomorphology and electron microscopic observation of R124L mutated corneal dystrophy in a relapsed pedigree.

    Fu MJ, Zhao J, Duan S, et al.

    International journal of ophthalmology 2022; (15(9)):1416-1422 doi:10.18240/ijo.2022.09.02.

    PMID: 36124191
  5. 5

    Bioresorbable silk grafts for small diameter vascular tissue engineering applications: In vitro and in vivo functional analysis.

    Gupta P, Lorentz KL, Haskett DG, et al.

    Acta biomaterialia 2020; (105()):146-158 doi:10.1016/j.actbio.2020.01.020.

    PMID: 31958596
  6. 6

    Clinical and Optical Coherence Tomography Correlation of Recurrence Patterns After Femtosecond Laser-Assisted Anterior Lamellar Keratoplasty in Reis-Bucklers Corneal Dystrophy.

    Chaurasia S, Mishra DK, Murthy S, et al.

    Cornea 2024; (43(4)):459-465 doi:10.1097/ICO.0000000000003387.

    PMID: 37713662
  7. 7

    Recurrence of macular corneal dystrophy on the graft 50 years after penetrating keratoplasty.

    Bischoff-Jung M, Flockerzi E, Hasenfus A, et al.

    GMS ophthalmology cases 2020; (10()):Doc34 doi:10.3205/oc000161.

    PMID: 32884888
  8. 8

    Clinical and genetic update of corneal dystrophies.

    Lisch W, Weiss JS

    Experimental eye research 2019; (186()):107715 doi:10.1016/j.exer.2019.107715.

    PMID: 31301286
  9. 9

    Granular corneal dystrophy recurrence at the posterior graft-host interface after type 1 big bubble deep anterior lamellar keratoplasty.

    Oke I, Haddad N, Lee HJ

    American journal of ophthalmology case reports 2020; (20()):100960 doi:10.1016/j.ajoc.2020.100960.

    PMID: 33117914
  10. 10

    Deep anterior lamellar keratoplasty and penetrating keratoplasty in macular corneal dystrophy: comparison of visual and topographic outcomes and complications.

    Balıkçı AT, Burcu A, Akkaya ZY, et al.

    Arquivos brasileiros de oftalmologia 2024; (87(3)):e20230109 doi:10.5935/0004-2749.2023-0109.

    PMID: 38537050
  11. 11

    Long-Term Observation of Deep Anterior Lamellar Keratoplasty in Patients with Post-LASIK Granular Corneal Dystrophy Type 2: Two Case Reports.

    Shinji K, Chikama T, Maruoka S, Kiuchi Y

    Ophthalmology and therapy 2021; (10(4)):1163-1169 doi:10.1007/s40123-021-00399-2.

    PMID: 34599746
  12. 12

    [Corneal dystrophies in optical coherence tomography].

    Elhardt C, Priglinger SG, Karakolova Y, et al.

    Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 2019; (116(9)):857-864 doi:10.1007/s00347-018-0832-8.

    PMID: 30539228
  13. 13

    Anterior Segment Optical Coherence Tomography in the Early Management of Microbial Keratitis: A Cross-Sectional Study.

    Oliveira MA, Rosa A, Soares M, et al.

    Acta medica portuguesa 2020; (33(5)):318-325 doi:10.20344/amp.12663.

    PMID: 31962057
  14. 14

    In vivo Imaging of Reis-Bücklers and Thiel-Behnke Corneal Dystrophies Using Anterior Segment Optical Coherence Tomography.

    Nishino T, Kobayashi A, Mori N, et al.

    Clinical ophthalmology (Auckland, N.Z.) 2020; (14()):2601-2607 doi:10.2147/OPTH.S265136.

    PMID: 32982153
  15. 15

    The Value of Anterior Segment Optical Coherence Tomography in Different Types of Corneal Infections: An Update.

    Abdelghany AA, D'Oria F, Alio Del Barrio J, Alio JL

    Journal of clinical medicine 2021; (10(13)) doi:10.3390/jcm10132841.

    PMID: 34199039
  16. 16

    Supra-Descemetic Venting Incision in the Management of Spontaneous Descemet Membrane Detachment in an Old Penetrating Keratoplasty Graft.

    Ramakrishnan S, Devarajan S, Srinivasan M, Karunakaran V

    Cornea 2021; (40(7)):921-925 doi:10.1097/ICO.0000000000002664.

    PMID: 33591031
  17. 17

    Phototherapeutic Keratectomy in Macular and Granular Dystrophy: Two-year Results.

    Kemer Atik B, Yildirim Y, Sonmez O, et al.

    Seminars in ophthalmology 2020; (35(3)):182-186 doi:10.1080/08820538.2020.1778743.

    PMID: 32529934
  18. 18

    Recurrence and Visual Outcomes of Phototherapeutic Keratectomy in Lattice Corneal Dystrophy: A Cohort Study.

    Sauvageot P, Julio G, Bolaños JV, et al.

    Journal of refractive surgery (Thorofare, N.J. : 1995) 2022; (38(1)):43-49 doi:10.3928/1081597X-20211104-01.

    PMID: 35020539
  19. 19

    Management of Stromal Corneal Dystrophies; Review of the Literature with a Focus on Phototherapeutic Keratectomy and Keratoplasty.

    Ashena Z, Niestrata M, Tavassoli S

    Vision (Basel, Switzerland) 2023; (7(1)) doi:10.3390/vision7010022.

    PMID: 36977302

This page provides educational information about the recurrence of corneal dystrophy after a transplant. It is not intended to replace professional medical advice, diagnosis, or routine monitoring by your ophthalmologist or corneal specialist.

Get notified when new evidence is published on Corneal dystrophy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.